Singular Genomics Systems, (id:8387 OMIC)
21.68 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/21/2024 6:47:02 PM)
Exchange closed, opens in 14 hours 42 minutes
About Singular Genomics Systems,
Market Capitalization 55.01M
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
| Headquarters (address) |
3010 Science Park Road San Diego 92121 CA United States |
| Phone | 858 333 7830 |
| Website | https://www.singulargenomics.com |
| Employees | 255 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Ticker | OMIC |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 5.34 - 23.41 |
| Market Capitalization | 55.01M |
| P/E trailing | -0.556 |
| P/E forward | -0.690 |
| Price/Sale | 20.20 |
| Price/Book | 0.301 |
| Beta | 1.51 |
| EPS | -34.68 |
| EPS United States (ID:6, base:3395) | 24.30 |